Beta cell function and mass in individuals with and without remission of type 2 diabetes after Roux-en-Y gastric bypass

Key Result

Individuals with remission of type 2 diabetes post-Roux-en-Y gastric bypass exhibited improved beta cell function and mass compared to those without remission.

Key Points

• The research aims to compare beta cell function and mass in individuals with and without remission of type 2 diabetes following Roux-en-Y gastric bypass.
• Conducted a clinical trial involving individuals undergoing Roux-en-Y gastric bypass
• Measured beta cell function and mass pre- and post-surgery
• Assessed remission status of type 2 diabetes in participants
• Individuals in remission showed improved beta cell function
• Beta cell mass differed significantly between groups post-surgery
• Enhanced insulin sensitivity was correlated with remission status